Walleye Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
|
|||||
|
2025
Q1 | $863K | Sell |
|
|||||
|
2024
Q4 | $3.27M | Buy |
|
|||||
|
2024
Q3 | $628K | Sell |
|
|||||
|
2024
Q2 | $1.69M | Buy |
|
|||||
|
2024
Q1 | $725K | Sell |
|
|||||
|
2023
Q4 | $7.6M | Buy |
|
|||||
|
2023
Q3 | $2.05M | Buy |
|
|||||
|
2023
Q2 | $569K | Sell |
|
|||||
|
2023
Q1 | $7.88M | Buy |
|
|||||
|
2022
Q4 | $2.04M | Sell |
|
|||||
|
2022
Q3 | $3.43M | Sell |
|
|||||
|
2022
Q2 | $3.32M | Buy |
|
|||||
|
2022
Q1 | $565K | Sell |
|
|||||
|
2021
Q4 | $1.51M | Sell |
|
|||||
|
2021
Q3 | $1.97K | Buy |
|
|||||
|
2021
Q2 | $463 | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $36K | Sell |
|
|||||
|
2019
Q3 | $283K | Buy |
|
|||||
|
2019
Q2 | – | Hold |
|